Alok Kripal Tewari, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Germ Cell and Embryonal | 3 | 2023 | 498 | 0.800 |
Why?
|
Androgen Antagonists | 3 | 2021 | 1412 | 0.640 |
Why?
|
Prostatic Neoplasms | 9 | 2024 | 11097 | 0.580 |
Why?
|
Orchiectomy | 3 | 2023 | 466 | 0.480 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.450 |
Why?
|
Metribolone | 1 | 2012 | 13 | 0.420 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2013 | 409 | 0.420 |
Why?
|
Receptors, Androgen | 4 | 2021 | 1089 | 0.410 |
Why?
|
Sp1 Transcription Factor | 1 | 2012 | 143 | 0.390 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2463 | 0.380 |
Why?
|
Repressor Proteins | 2 | 2023 | 2979 | 0.380 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2021 | 1536 | 0.340 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5794 | 0.320 |
Why?
|
Chromatin | 4 | 2022 | 2980 | 0.300 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 806 | 0.280 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7611 | 0.260 |
Why?
|
Genomics | 2 | 2021 | 5924 | 0.240 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5332 | 0.230 |
Why?
|
Seminoma | 1 | 2023 | 136 | 0.200 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2013 | 304 | 0.200 |
Why?
|
Phthalazines | 1 | 2024 | 397 | 0.190 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11872 | 0.190 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2024 | 249 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 194 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2021 | 3944 | 0.180 |
Why?
|
Proteoglycans | 2 | 2013 | 807 | 0.170 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 301 | 0.170 |
Why?
|
Transcription Factors | 5 | 2022 | 12158 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 802 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 531 | 0.150 |
Why?
|
Prostatectomy | 2 | 2021 | 1786 | 0.150 |
Why?
|
Immunologic Factors | 2 | 2021 | 1592 | 0.150 |
Why?
|
Gene Library | 1 | 2021 | 1065 | 0.150 |
Why?
|
Quality Control | 1 | 2021 | 835 | 0.150 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.140 |
Why?
|
Gene Dosage | 1 | 2021 | 1211 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 724 | 0.130 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4780 | 0.130 |
Why?
|
Immunotherapy | 4 | 2024 | 4745 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1061 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2021 | 8628 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3667 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1885 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2548 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2021 | 1758 | 0.110 |
Why?
|
Epothilones | 1 | 2013 | 42 | 0.110 |
Why?
|
Tubulin Modulators | 1 | 2013 | 106 | 0.100 |
Why?
|
Stilbenes | 1 | 2012 | 155 | 0.100 |
Why?
|
Binding Sites | 3 | 2022 | 6014 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 208 | 0.100 |
Why?
|
Deoxyribonuclease I | 1 | 2012 | 228 | 0.090 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2013 | 590 | 0.090 |
Why?
|
Pyrimidines | 2 | 2021 | 3044 | 0.090 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2013 | 496 | 0.090 |
Why?
|
Tumor Escape | 1 | 2013 | 371 | 0.090 |
Why?
|
Melanoma, Experimental | 1 | 2013 | 557 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9532 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.080 |
Why?
|
Primates | 1 | 2012 | 519 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9606 | 0.080 |
Why?
|
Male | 17 | 2024 | 364203 | 0.080 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 17097 | 0.080 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 792 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13650 | 0.080 |
Why?
|
Humans | 27 | 2024 | 767040 | 0.070 |
Why?
|
Drug Design | 1 | 2013 | 1045 | 0.070 |
Why?
|
Microtubules | 1 | 2013 | 1062 | 0.070 |
Why?
|
Genome, Human | 3 | 2022 | 4441 | 0.070 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 590 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 682 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2012 | 998 | 0.070 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 263 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3186 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1266 | 0.060 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2005 | 222 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1671 | 0.060 |
Why?
|
Mutation | 4 | 2024 | 30211 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 896 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4282 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6966 | 0.060 |
Why?
|
Evolution, Molecular | 1 | 2012 | 1893 | 0.060 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4892 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2023 | 175 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3608 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3854 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9108 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8048 | 0.050 |
Why?
|
Robotics | 1 | 2008 | 807 | 0.050 |
Why?
|
Dietary Fats | 1 | 2009 | 2001 | 0.050 |
Why?
|
Insulin | 2 | 2012 | 6602 | 0.040 |
Why?
|
Neoplasms | 2 | 2021 | 22350 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5363 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2024 | 812 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6360 | 0.040 |
Why?
|
Signal Transduction | 4 | 2021 | 23621 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18063 | 0.040 |
Why?
|
Protein Binding | 3 | 2022 | 9327 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3828 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2023 | 1267 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1759 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 632 | 0.030 |
Why?
|
Laparoscopy | 1 | 2008 | 2037 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 854 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 754 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 561 | 0.030 |
Why?
|
Mice, SCID | 2 | 2012 | 2626 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1836 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3488 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1712 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1144 | 0.030 |
Why?
|
Animals | 7 | 2024 | 168965 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1110 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1362 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9517 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2013 | 48 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2353 | 0.030 |
Why?
|
Chemokine CCL22 | 1 | 2013 | 27 | 0.030 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 117 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 259 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11923 | 0.020 |
Why?
|
Mice | 5 | 2024 | 81912 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2013 | 748 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81659 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7587 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4026 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2012 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 715 | 0.020 |
Why?
|
Genes, p53 | 1 | 2012 | 711 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6777 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3797 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59548 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 126 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 584 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11217 | 0.020 |
Why?
|
Ketones | 1 | 2009 | 183 | 0.020 |
Why?
|
Aminopyridines | 1 | 2012 | 578 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4854 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2412 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2012 | 877 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 416 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4648 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1492 | 0.020 |
Why?
|
Quinolines | 1 | 2012 | 770 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 539 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65295 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2931 | 0.020 |
Why?
|
Medication Adherence | 1 | 2018 | 2191 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 1169 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3804 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 1995 | 0.020 |
Why?
|
Ribonuclease H | 1 | 2005 | 52 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9410 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2394 | 0.010 |
Why?
|
Neural Stem Cells | 1 | 2012 | 895 | 0.010 |
Why?
|
Cerebellum | 1 | 2012 | 1521 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2005 | 654 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6226 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 1 | 2005 | 214 | 0.010 |
Why?
|
Retroelements | 1 | 2005 | 162 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9612 | 0.010 |
Why?
|
Aged | 3 | 2024 | 171319 | 0.010 |
Why?
|
Middle Aged | 4 | 2024 | 223233 | 0.010 |
Why?
|
Models, Chemical | 1 | 2005 | 607 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2005 | 699 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2061 | 0.010 |
Why?
|
Fatty Liver | 1 | 2009 | 811 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4306 | 0.010 |
Why?
|
Alanine | 1 | 2005 | 613 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2843 | 0.010 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2005 | 481 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2013 | 2745 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1677 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 6210 | 0.010 |
Why?
|
Thiazoles | 1 | 2009 | 1530 | 0.010 |
Why?
|
Androgens | 1 | 2009 | 1281 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1939 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15824 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2827 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9551 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2457 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10092 | 0.010 |
Why?
|
Point Mutation | 1 | 2005 | 1591 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12793 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3760 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15567 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4572 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12536 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1801 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54886 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10455 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11657 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3986 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22361 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6421 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2678 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16718 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13411 | 0.010 |
Why?
|
Apoptosis | 1 | 2009 | 9513 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5693 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17608 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18330 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13646 | 0.010 |
Why?
|
Female | 3 | 2021 | 396660 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7210 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 18989 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6951 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39317 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40154 | 0.000 |
Why?
|